Mitoxantrone Completed Phase 4 Trials for Autoimmune Diseases of the Nervous System / Demyelinating Autoimmune Diseases, CNS / Transverse Myelitis / Neuromyelitis Optica Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00304291A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)